Lupin gets inspection report from USFDA for Nagpur facility

Lupin said it has received an establishment inspection report (EIR) from the US health regulator post the inspection of its Nagpur facility. “The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection for its Phenytoin Sodium Extended Release 100 mg capsules,” Lupin said in a filing to the stock exchange. The plant was inspected by USFDA in September 2018, the company added.
USFDA gives EIR on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection. Commenting on the development, Lupin MD Mr. Nilesh Gupta said, “The successful completion of the Nagpur facility inspection is a positive development as we continue our journey to meet and exceed international regulatory standards.”
2026-10-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
-
FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food
-
FDA Issues Warning to Produce Importer for Non-Compliance
-
FDA Proposes Ban on Hair Relaxers Containing Formaldehyde
Recommend Reading
-
Titanium Dioxide Prices Are Up Again! This Round of Increases Has One Real Driver: Sulfuric Acid
-
Middle East Crude Exports Rebound Sharply in September as Saudi Arabia Returns to Market at 5.4 Million bpd
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
New York Targets Additives and GRAS Disclosure
-
India Raises Cancer Drug Price Caps by 50%
-
Returning to Fundamentals: Ethylene Glycol Prices in April Show Volatile and Weak Trends
-
Both Cost and Demand Weighing Down PTA Prices, Leading to Volatile Declines
-
Recent Continuous Decline in the Ethyl Acetate Market in China
-
Production and Sales Pressure Eases; PC Prices Stabilize for Late November
-
Monthly Drop Nears 5%! Acrylic Acid Prices Fall Below Average, Decline Officially Confirmed